EUVIMEDOpdag EUVIMED
Crossref

Red Blood Cell Membrane Spontaneously Coated Nanoprodrug Based on Phosphatidylserine for Antiatherosclerosis Applications

Yu Cao, ZhiQiang Han, Li Zhu, Zhigui He, Nianlian Mou, Xinmei Duan, Qiao Chen, Xian Qin, Kun Zhang, Kai Qu, Yuan Zhong, Wei Wu iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c07720 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2024. Written by Yu Cao and 11 co-authors. Institution: Key Laboratory for Bioarcheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implan…. Major MEDLINE topics: Erythrocyte Membrane, Atherosclerosis, Phosphatidylserines. Cited 19 times so far (Crossref); 32 references. Funded by: Natural Science Foundation of Chongqing Municipality, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Atherosclerosis (AS) is characterized by the accumulation of lipids within the walls of coronary arteries, leading to arterial narrowing and hardening. It serves as the primary etiology and pathological basis for cardiovascular diseases affecting the heart and brain. However, conventional pharmacotherapy is constrained by inadequate drug delivery and pronounced toxic side effects. Moreover, the inefficacy of nanomedicine delivery systems in controlling disease progression may be attributed to nonspecific clearance by the mononuclear phagocyte system. Thus, a biomimetic platform spontaneously enveloped by red blood cell membrane is exploited for anti-atherosclerosis applications, offering favorable biocompatibility. The CLIKKPF polypeptide is introduced to develop red blood cell membrane spontaneously encapsulated nanotherapeutics only through simple coincubation. Given the functional modifications, RBC@P-LVTNPs is beneficial to facilitate the target drug delivery to the atherosclerotic lesion, responding precisely to the pathological ROS accumulation, thereby accelerating the on-demand drug release. Both in vivo and in vitro results also confirm the significant therapeutic efficacy and favorable biocompatibility of the biomimetic nanomedicine delivery system, thus providing a promising candidate for nanotherapeutics against AS.

Subjects

MeSH terms (MEDLINE)

Erythrocyte MembraneAtherosclerosisPhosphatidylserinesAnimalsHumansMiceProdrugsNanoparticlesReactive Oxygen SpeciesMale

Author keywords

atherosclerosisphosphatidylserinereactive oxygen speciesred blood cell membranetarget drug delivery

Substances

PhosphatidylserinesProdrugsReactive Oxygen Species

Authors and institutions

  • Key Laboratory for Bioarcheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing 400044,…
  • Chongqing University Three Gorges Hospital, Chongqing Municipality Clinical Research Center for Endocrinology and Metabolic Diseases, Chongqing 404000, China.
  • JinFeng Laboratory, Chongqing 401329, China.

ORCID profiles: Wei Wu

Funding

  • Natural Science Foundation of Chongqing Municipality
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • JinFeng Laboratory of Chongqing
  • Fundamental Research Funds for the National Key R&D Project

Cite

APA

Cao, Y., Han, Z., Zhu, L., He, Z., Mou, N., Duan, X., Chen, Q., Qin, X., Zhang, K., Qu, K., Zhong, Y., & Wu, W. (2024). Red Blood Cell Membrane Spontaneously Coated Nanoprodrug Based on Phosphatidylserine for Antiatherosclerosis Applications. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c07720

Vancouver

Cao Y, Han Z, Zhu L, He Z, Mou N, Duan X, et al. Red Blood Cell Membrane Spontaneously Coated Nanoprodrug Based on Phosphatidylserine for Antiatherosclerosis Applications. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c07720

BibTeX
@article{Cao2024,
  author = {Cao, Yu and Han, ZhiQiang and Zhu, Li and He, Zhigui and Mou, Nianlian and Duan, Xinmei and Chen, Qiao and Qin, Xian and Zhang, Kun and Qu, Kai and Zhong, Yuan and Wu, Wei},
  title = {Red Blood Cell Membrane Spontaneously Coated Nanoprodrug Based on Phosphatidylserine for Antiatherosclerosis Applications},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c07720}
}
Start for free →